A. Hantel

744 total citations · 1 hit paper
7 papers, 429 citations indexed

About

A. Hantel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A. Hantel has authored 7 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in A. Hantel's work include Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Colorectal Cancer Surgical Treatments (2 papers). A. Hantel is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Colorectal Cancer Surgical Treatments (2 papers). A. Hantel collaborates with scholars based in United States, Mexico and Canada. A. Hantel's co-authors include Leonard B. Saltz, Richard M. Goldberg, Donna Hollis, Donna Niedzwiecki, Lee Jones, Erin B. Kennedy, Y. Nancy You, Emily K. Bergsland, Christopher H. Lieu and Philip J. Gold and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and PubMed.

In The Last Decade

A. Hantel

7 papers receiving 417 citations

Hit Papers

Adjuvant Therapy for Stage II Colon Cancer: ASCO Guidelin... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Hantel United States 6 328 142 106 100 88 7 429
Cédric Lecaille France 11 284 0.9× 98 0.7× 123 1.2× 69 0.7× 143 1.6× 21 449
Faisal Shahjehan United States 10 264 0.8× 92 0.6× 115 1.1× 69 0.7× 83 0.9× 26 370
Meijiao Zhou United States 9 300 0.9× 164 1.2× 83 0.8× 58 0.6× 123 1.4× 20 377
Whitney F. Jones United States 6 313 1.0× 231 1.6× 113 1.1× 32 0.3× 87 1.0× 9 430
Huub M. Kluck Netherlands 8 311 0.9× 92 0.6× 74 0.7× 148 1.5× 81 0.9× 8 387
Alessandra Boccaccino Italy 12 344 1.0× 152 1.1× 81 0.8× 77 0.8× 113 1.3× 37 379
Yves Rinaldi France 11 343 1.0× 60 0.4× 63 0.6× 98 1.0× 132 1.5× 47 410
E. Dotor Spain 10 270 0.8× 67 0.5× 96 0.9× 154 1.5× 70 0.8× 23 462
Maria Banzi Italy 14 382 1.2× 102 0.7× 69 0.7× 94 0.9× 161 1.8× 49 500
J S Byeon South Korea 5 468 1.4× 231 1.6× 119 1.1× 56 0.6× 314 3.6× 13 620

Countries citing papers authored by A. Hantel

Since Specialization
Citations

This map shows the geographic impact of A. Hantel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hantel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hantel more than expected).

Fields of papers citing papers by A. Hantel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hantel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hantel. The network helps show where A. Hantel may publish in the future.

Co-authorship network of co-authors of A. Hantel

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hantel. A scholar is included among the top collaborators of A. Hantel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hantel. A. Hantel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Baxter, Nancy N., Erin B. Kennedy, Emily K. Bergsland, et al.. (2021). Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 40(8). 892–910. 155 indexed citations breakdown →
2.
Lieu, Christopher H., Erin B. Kennedy, Emily K. Bergsland, et al.. (2019). Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline. Journal of Clinical Oncology. 37(16). 1436–1447. 55 indexed citations
3.
Ogino, Shuji, J. A. Meyerhardt, Anthony T.�C. Chan, et al.. (2011). Relationship Between Statin Use and Colon Cancer Recurrence and Survival: Results From CALGB 89803. JNCI Journal of the National Cancer Institute. 103(20). 1540–1551. 71 indexed citations
4.
Saltz, Leonard B., Donna Niedzwiecki, Donna Hollis, et al.. (2004). Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803). Journal of Clinical Oncology. 22(14_suppl). 3500–3500. 74 indexed citations
5.
Saltz, Leonard B., Donna Niedzwiecki, Donna Hollis, et al.. (2004). Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803). Journal of Clinical Oncology. 22(14_suppl). 3500–3500. 39 indexed citations
6.
Noe, D A, Eric K. Rowinsky, L B Grochow, et al.. (1990). Phase I and pharmacokinetic study of brequinar sodium (NSC 368390).. PubMed. 50(15). 4595–9. 32 indexed citations
7.
Hantel, A., Eric K. Rowinsky, D A Noe, et al.. (1988). Clinical and Pharmacologic Reappraisal of Dichloromethotrexate. JNCI Journal of the National Cancer Institute. 80(19). 1547–1553. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026